Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cofrogliptin in prediabetes
ChiCTR2600135007Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cofrogliptin in prediabetes, sponsored by Tongji Hospital. Primary endpoint: Clinical remission rate of patients with prediabetes at 12 months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
cofrogliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR2600135007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135007.